Sent to MediPurpose's shareholders earlier this week, the letter is published on the company's Website and is also available for download.
Written by MediPurpose's founder and CEO Patrick Yi, the letter summarizes key achievements and activities for the company's various business segments and corporate units in FY 2013:
* Blood Collection & Analytics (which includes SurgiLance(tm)
* Advanced Wound Care (which includes MediPlus(tm)
* New Business Development
* Corporate Organization
* Inbound Marketing
* Operations (which includes Medical Device Innovation and Medical Product Distribution)
Yi is optimistic about his company's continued success. "Ideas and opportunities abound," said Yi. "However, implementation is the key to success-and there are no shortcuts in the regulated medical device market. We are committed to developing innovative and safe medical products and bringing quality products to the world healthcare market."
To download the letter, please visit http://www.medipurpose.com/
For more information about MediPurpose's medical products -- including pricing and no-cost product sample requests -- please visit http://www.medipurpose.com/
Founded in 1999, MediPurpose is an innovative medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance(tm)
MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors that seek entrance into new medical device markets.
For more information about MediPurpose's medical products and solutions for inventors, innovators, manufacturers and distributors, please visit http://www.medipurpose.com .